SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
The EPA formally declared Thursday that weedkiller chemical glyphosate poses no threat to human health. Activists were outraged. (Photo: AFP/Getty Images)
Critics: Trump EPA's Formal Assertion Glyphosate Poses No Risk to Human Health Indication of 'Troubling Allegiance' With Bayer/Monsanto
"It's open season on clean air, water, and soil."
Jan 29, 2020
President Donald Trump's Environmental Protection Agency on Thursday wrapped up a regulatory review of the safety of the weedkiller glyphosate and found the chemical poses no risk to human healh--a decision that was immediately decried by advocates as another indication of the closeness between the administration and private sector interests.
"The Trump EPA's assertion that glyphosate poses no risks to human health disregards independent science findings in favor of confidential industry research and industry profits," said Lori Ann Burd, the Center for Biological Diversity's director of environmental health. "This administration's troubling allegiance to Bayer/Monsanto and the pesticide industry doesn't change the trove of peer-reviewed research by leading scientists finding troubling links between glyphosate and cancer."
The EPA came to the conclusion after reviewing the chemical's effects on humans, but the determination is unlikely to change views on either side of the conflict over the chemical's safety.
"A whole lot of people will disagree" with the EPA, tweeted Civil Eats founder and editor Naomi Starkman.
As Reuters reported:
The conclusion reaffirms the agency's stance on glyphosate, the key ingredient in Bayer AG's Roundup, despite judgments by U.S. juries that have found that use of the weedkiller was responsible for plaintiffs' cancer in some trials.
...
In 2015, the World Health Organization's cancer arm classified glyphosate as "probably carcinogenic to humans."
There are reportedly tens of thousands of lawsuits against Bayer/Monsanto for the chemical's cancer links, and the company is considering settling the claims for between $10 and $12 billion.
Thursday's decision is not expected to have an effect on those suits. But the message the EPA is sending, the Center for Biological Diversity's Burd said, is clear.
"The EPA's pesticide office is clearly willing to bend over backwards, including disregarding its own guidelines for evaluating cancer risks, to give the industry what it wants," said Burd.
As Common Dreams has reported, Trump's EPA has been criticized by advocates for years for its closeness to Bayer/AG and its treatment of glyphosate.
Media strategist Jen Degtjarewsky gave a blunt assessment on the president's environmental record in the contexxt of Thursday's ruling.
"It's open season on clean air, water, and soil," said Degtjarewsky.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
President Donald Trump's Environmental Protection Agency on Thursday wrapped up a regulatory review of the safety of the weedkiller glyphosate and found the chemical poses no risk to human healh--a decision that was immediately decried by advocates as another indication of the closeness between the administration and private sector interests.
"The Trump EPA's assertion that glyphosate poses no risks to human health disregards independent science findings in favor of confidential industry research and industry profits," said Lori Ann Burd, the Center for Biological Diversity's director of environmental health. "This administration's troubling allegiance to Bayer/Monsanto and the pesticide industry doesn't change the trove of peer-reviewed research by leading scientists finding troubling links between glyphosate and cancer."
The EPA came to the conclusion after reviewing the chemical's effects on humans, but the determination is unlikely to change views on either side of the conflict over the chemical's safety.
"A whole lot of people will disagree" with the EPA, tweeted Civil Eats founder and editor Naomi Starkman.
As Reuters reported:
The conclusion reaffirms the agency's stance on glyphosate, the key ingredient in Bayer AG's Roundup, despite judgments by U.S. juries that have found that use of the weedkiller was responsible for plaintiffs' cancer in some trials.
...
In 2015, the World Health Organization's cancer arm classified glyphosate as "probably carcinogenic to humans."
There are reportedly tens of thousands of lawsuits against Bayer/Monsanto for the chemical's cancer links, and the company is considering settling the claims for between $10 and $12 billion.
Thursday's decision is not expected to have an effect on those suits. But the message the EPA is sending, the Center for Biological Diversity's Burd said, is clear.
"The EPA's pesticide office is clearly willing to bend over backwards, including disregarding its own guidelines for evaluating cancer risks, to give the industry what it wants," said Burd.
As Common Dreams has reported, Trump's EPA has been criticized by advocates for years for its closeness to Bayer/AG and its treatment of glyphosate.
Media strategist Jen Degtjarewsky gave a blunt assessment on the president's environmental record in the contexxt of Thursday's ruling.
"It's open season on clean air, water, and soil," said Degtjarewsky.
President Donald Trump's Environmental Protection Agency on Thursday wrapped up a regulatory review of the safety of the weedkiller glyphosate and found the chemical poses no risk to human healh--a decision that was immediately decried by advocates as another indication of the closeness between the administration and private sector interests.
"The Trump EPA's assertion that glyphosate poses no risks to human health disregards independent science findings in favor of confidential industry research and industry profits," said Lori Ann Burd, the Center for Biological Diversity's director of environmental health. "This administration's troubling allegiance to Bayer/Monsanto and the pesticide industry doesn't change the trove of peer-reviewed research by leading scientists finding troubling links between glyphosate and cancer."
The EPA came to the conclusion after reviewing the chemical's effects on humans, but the determination is unlikely to change views on either side of the conflict over the chemical's safety.
"A whole lot of people will disagree" with the EPA, tweeted Civil Eats founder and editor Naomi Starkman.
As Reuters reported:
The conclusion reaffirms the agency's stance on glyphosate, the key ingredient in Bayer AG's Roundup, despite judgments by U.S. juries that have found that use of the weedkiller was responsible for plaintiffs' cancer in some trials.
...
In 2015, the World Health Organization's cancer arm classified glyphosate as "probably carcinogenic to humans."
There are reportedly tens of thousands of lawsuits against Bayer/Monsanto for the chemical's cancer links, and the company is considering settling the claims for between $10 and $12 billion.
Thursday's decision is not expected to have an effect on those suits. But the message the EPA is sending, the Center for Biological Diversity's Burd said, is clear.
"The EPA's pesticide office is clearly willing to bend over backwards, including disregarding its own guidelines for evaluating cancer risks, to give the industry what it wants," said Burd.
As Common Dreams has reported, Trump's EPA has been criticized by advocates for years for its closeness to Bayer/AG and its treatment of glyphosate.
Media strategist Jen Degtjarewsky gave a blunt assessment on the president's environmental record in the contexxt of Thursday's ruling.
"It's open season on clean air, water, and soil," said Degtjarewsky.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.